Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase
Martina Ott(German Cancer Research Center), Michael Platten(National Center for Tumor Diseases)
Cited by 50
Related Papers
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
|Oncotarget|2014|309
The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
|PLoS ONE|2011|143
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|14